My tailored session combined life coaching, hypnotherapy, meditation, breathwork, vision-crafting skills and strategic ...
Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...
The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...
Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...
GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adults with relapsed or refractory osteosarcoma.
Koreas Resolute gains FDA breakthrough therapy designation for RZ358 treatment Resolute receives FDA recognition for ...
GSK5764227 (HS-20093) is a novel antibody-drug conjugate composed of a fully human anti-B7-H3 monoclonal antibody covalently linked to a topoisomerase inhibitor payload.
After a heart attack, humans lose millions of heart muscle cells that cannot regrow, often leading to heart failure where the ...
The trial, which will involve around 350 patients with reduced ejection fraction, will begin enrolling in early 2025.
UC San Diego Health one of a few health care systems on West Coast to offer new gene therapy for hemophilia B.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback